Dr Agarwal's Healthcare may additionally release IPO among Jan 29-31; valuation between Rs 12,700-Rs 12,900 crore
TPG and Temasek-sponsored top eye care offerings issuer Dr Agarwal's Healthcare, the determine of listed firm Dr Agarwal's Eye health facility, is making plans to release it's initial public provide (IPO) among january 29 to january 31 at a post-money valuation of Rs 12,700 crore to Rs 12,900 crore, a couple of enterprise resources within the recognize advised Moneycontrol .
The anchor ebook component is deliberate for january 28, these sources added.
An email query to Dr Agarwal's Healthcare remained unanswered on the time of publishing this newsletter.
The company, which had filed its draft papers on september 27, holds a seventy one.nine percent stake in subsidiary Dr Agarwal's Eye hospital that became integrated lower back in 1994.
As in step with the draft papers, the IPO is a combination of sparkling problem of fairness shares well worth Rs 300 crore by using the employer, and a suggestion-for-sale of 6.95 crore equity shares by means of promoters and buyers.
Moneycontrol turned into the first to report in march 2024
that Dr Agarwals Healthcare had engaged investment banks as advisors and kicked off the method to release an initial public offer and raise around Rs three,000 crore in FY25.
Over and above the promoter institution, TPG and Temasek could be the selling shareholders in the provide-for-sale ( OFS)
The promoters personal a 37.83 percentage stake in Dr Agarwal's Healthcare. TPG holds 33.75 consistent with cent whilst Temasek holds 28.18 in line with cent.
Kotak mahindra Capital, Jefferies, Morgan Stanley and Motilal oswal are the merchant bankers to the problem through Dr Agarwal's Healthcare.
a better have a look at Dr Agarwal's Healthcare
With one hundred sixty five facilities in india and 15 globally (along with 9 in Africa), the tamil Nadu-based company provides eye care offerings along with cataract, refractive, and other surgical procedures as well as sells opticals, contact lenses and add-ons, and eye care-related pharmaceutical products. It had a marketplace proportion of about 25 percent of the entire eye care service chain marketplace in india for the duration of the fiscal 2024.
Dr Agarwal's Healthcare will utilise Rs 195 crore out of the net clean difficulty proceeds for repaying its debt, and the final funds for popular corporate functions and inorganic growth as in line with the draft papers.
The indian eye care enterprise is projected to develop at a CAGR of 12-14 percent from FY24 to FY28. the size of the indian eye care offerings industry was approximately Rs 37,800 crore in monetary 2024 and is projected to develop to Rs fifty five,000-65,000 crore by means of FY28, as per the draft papers of Dr Agarwal's Healthcare.
click and follow Indiaherald WhatsApp channel